JA REDACTED.pdf

This is a Justification and Approval (J&A) for Other than Full and Open Competition document for a sole source acquisition by the Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division-West to procure AD1K-050 consumable blood kits from Nanoentek America, Inc. in Waltham, Massachusetts.

The J&A supports a one-time firm-fixed-price purchase order for blood testing kits used with ADAM-rWBC 1 & 2 machines at Naval Hospital Guam's Blood Bank/Laboratory. Nanoentek America is identified as the sole manufacturer and authorized distributor of these FDA-required kits for counting residual white blood cells in leukoreduced blood products. The base period delivery date is January 20, 2026, with four one-year option periods through January 20, 2030. Market research conducted in December 2024 confirmed no other vendors could meet the requirements. A Notice of Intent (NOI #HT941025N0021) was posted on SAM.gov from December 23-27, 2024, with no additional sources identified. The contract will be funded through Operations and Maintenance (O&M) funds.